Research publications

Acute pyelonephritis: management steps that remain unresolved

Peleg AY, MacLaren G, Hoy J

(2007), Clin Infect Dis, 45(9), 1249

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

Owen RJ, Li J, Nation RL, Spelman D

(2007), J Antimicrob Chemother, 59(3), 473-7

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D

(2007), Addiction, 102(4), 616-22

Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified

Nielsen S, Dietze P, Dunlop A, Muhleisen P, Lee N, Taylor D

(2007), Drug Alcohol Rev, 26(2), 143-51

Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study

Nguyen OK, Dore GJ, Kaldor JM, Hellard ME; ATAHC Protocol Steering Committee

(2007), Int J Drug Policy, 18(5), 447-51

Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A

Morrissey CO, Slavin MA, O'Reilly MA, Daffy JR, Seymour JF, Schwarer AP, Szer J

(2007), Mycoses, 50(s1), 24–37

Immune responses to abacavir in antigen-presenting cells from hypersensitive patients

Martin AM, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, McCluskey J, Phillips E, Landay A, Mallal S

(2007), AIDS, 21(10), 1233-44

A longitudinal study of Acinetobacter in three Australian hospitals

Marshall C, Richards M, Black J, Sinickas V, Dendle C, Korman T, Spelman D

(2007), J Hosp Infect, 67(3), 245-52

4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention

Maher L, Tachedjian G, Hoy JF, Millwood I, Guy RJ, Walsh NM, Zaunders JJ, Jaworowski A, Kaldor JM

(2007), Med J Aust, 187(11-12), 610-2

Sexual-risk behaviour, self-perceived risk and knowledge of sexually transmissible infections among young Australians attending a music festival

Lim MS, Hellard ME, Aitken CK, Hocking JS

(2007), Sex Health, 4(1), 51-6

Blood-borne viruses and risk behaviours among injecting drug users recruited from needle and syringe programs in Victoria's eastern metropolitan region

Lim M, Sundaram K, Aitken C, Hellard M

(2007), Aust J Primary Health, 13(3), 69-76

Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains

Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C

(2007), Clin Infect Dis, 45(5), 594-8

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

Lazzarin A, Campbell T, Clotet B, Johnson M, Katlama C, Moll A, Towner W, Trottier B, Peeters M, Vingerhoets J, de Smedt G, Baeten B, Beets G, Sinha R, Woodfall B; DUET-2 study group

(2007), Lancet, 370(9581), 39-48

Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B

Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV

(2007), Antivir Ther, 12(5), 705-18

Propionibacterium endocarditis: a case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study

Lalani T, Person AK, Hedayati SS, Moore L, Murdoch DR, et al; International Collaboration on Endocarditis Merged; Database Study Group

(2007), Scand J Infect Dis, 39(10), 840-8

Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy

Lactic Acidosis International Study Group

(2007), AIDS, 21(18), 2455-64

Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours

Lacey C, Ellen S, Devlin H, Wright E, Mijch A

(2007), Australas Psychiatry, 15(4), 315-9

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1

Katlama C, Esposito R, Gatell JM, Goffard JC, Grinsztejn B, Pozniak A, Rockstroh J, Stoehr A, Vetter N, Yeni P, Parys W, Vangeneugden T; the POWER 1 study group

(2007), AIDS, 21(4), 395-402

CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection

Jaworowski A, Kamwendo DD, Ellery P, Sonza S, Mwapasa V, Tadesse E, Molyneux ME, Rogerson SJ, Meshnick SR, Crowe SM

(2007), J Infect Dis, 196(1), 38-42

Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings

Iqbal HS, Balakrishnan P, Cecelia AJ, Solomon S, Kumarasamy N, Madhavan V, Murugavel KG, Ganesh AK, Solomon SS, Mayer KH, Crowe SM

(2007), J Med Microbiol, 56(Pt 12), 1611-4

Publication Details